Welcome to the Cancer Diagnosis Program!
The Cancer Diagnosis Program strives to improve the diagnosis and assessment of cancer by effectively moving new scientific knowledge into clinical practice. This national program stimulates, coordinates and funds resources and research for the development of innovative in vitro diagnostics, novel diagnostic technologies and appropriate human specimens in order to better characterize cancers and allow improved medical decision making and evaluation of response to treatment.
For more information about the Cancer Diagnosis Program and its Branches, please click here.
News and Announcements
07/2018
Check out new publications by the CDP Staff! Learn more about Circulating Tumor DNA Assays in Clinical Cancer Research, a blog and paper on returning incidental findings in the Genotype-Tissue Expression (GTEx) project, and the fundamental issues of biomarkers in early-phase trials. See what else we're writing about on our CDP Publications page.
03/2018
New publications by CDP staff! Learn about genetic differences in adult and adolescent-and-young adult colon cancer, donor views on broad consent for tissue donation, and the effects of preanalytical variables on clinical biomarkers of oncology and immunotherapy. See what else we're writing about on our CDP Publications page.
03/2018
Academic-Industrial Partnership (AIP) award made. CDP together with the Cancer Imaging Program is funding a new effort to predict the aggressiveness of lung cancer.
01/2018
New funding opportunity: Academic-Industrial Partnership for Translation of Technologies for Diagnosis and Treatment accepting submissions beginning February 28th, 2018. See more FOAs on our funding opportunities page.
Sign up for Email Updates
Follow us on Twitter
Contact Us